Jade Biosciences, Inc. (JBIO) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$113.54M | -52.2% |
| 2024 | -$74.60M | +8.4% |
| 2023 | -$81.41M | -52.9% |
| 2022 | -$53.24M | -131.2% |
| 2021 | -$23.02M | -159.0% |
| 2020 | -$8.89M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$113.54M | -52.2% |
| 2024 | -$74.60M | +8.4% |
| 2023 | -$81.41M | -52.9% |
| 2022 | -$53.24M | -131.2% |
| 2021 | -$23.02M | -159.0% |
| 2020 | -$8.89M | — |